Solvay, headquartered in Brussels, is a leading global supplier of specialty polymers, introduced new Zeniva ZA-600 CF30 polyetheretherketone (PEEK), a 30 percent carbon fiber-reinforced, radiolucent polymer offered for implantable device applications. Zeniva ZA-600 CF30 PEEK offers modulus very similar to cortical bone that can help implants minimize the reduction in bone density by maintaining normal stress on surrounding bone tissue.
Zeniva ZA-600 CF30 PEEK is excellent for structural, load-bearing, implantable devices used in spine, hip and knee replacements reducing the size and scale of their implanted devices to make them less intrusive. Zeniva ZA-600 CF30 polymer also provides exceptional creep resistance and the ability to withstand prolonged fatigue strain.
Jeff Hrivnak, business manager for Healthcare at Solvay’s Specialty Polymers global business unit, said, “Zeniva ZA-600 PEEK CF30 offers the orthopedic industry an innovative new structural material with the potential to dramatically reduce the manufacturing costs of implantable devices used for sports medicine, trauma, and joint reconstruction. Optimized for injection molding, this material opens the door to cost-effective, large-scale production of implants, offering OEMs the economic advantage they need to compete and succeed in this fast-growing market.”
Zeniva ZA-600 CF30 PEEK, manufactured in a dedicated ISO 13485- and cGMP-compliant facility in the U.S. is tested in ISO 17025 labs. It is used in orthopedics, cardiovascular, spine, and other applications. As with all Solviva Biomaterials, production of Zeniva PEEK polymer is carefully validated and enhanced controls provide product traceability. Detailed FDA Master Access Files (MAF) are available for the new material, along with additional regulatory support to help streamline customers’ time-to-market. Solvay’s products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability.